g-Nomic: a new pharmacogenetics interpretation software.

Area of Science:

• Pharmacogenetics and Computational Drug Safety
• Biomarker Discovery and Personalized Medicine
• Drug Metabolism and Interaction Analysis

Background:

• Personalized medicine requires comprehensive analysis of individual factors influencing drug efficacy and safety.
• Existing drug interaction checkers often lack integration of genetic data and lifestyle variables.
• Accurate pharmacogenetic interpretation is crucial for optimizing drug therapy and minimizing adverse events.

Purpose of the Study:

• To introduce g-Nomic, a novel software tool for integrated pharmacogenetic and drug interaction analysis.
• To provide personalized recommendations on medication suitability based on genetic makeup, drug interactions, and lifestyle.
• To enhance the safety and efficacy of drug prescriptions through a user-friendly platform.

Main Methods:

• g-Nomic analyzes prescribed medications considering genetics, drug-drug interactions, lifestyle, and metabolism pathways.
• The software accesses FDA/EMA drug labels and PubMed for pharmacokinetic data, including CYP-450 enzyme interactions.
• It incorporates common/commercial drug names, non-pharmacological substances, and lifestyle habits into its analysis.

Main Results:

• g-Nomic identifies primary biomarker genes for potential genetic testing and lists detected interactions.
• The software distinguishes between drugs and prodrugs and provides recommendations based on available genetic information.
• It dynamically updates its database monthly with new drugs, interactions, and pharmacokinetic biomarkers.

Conclusions:

• g-Nomic offers a user-friendly tool for safer prescriptions by integrating diverse patient-specific data.
• The software facilitates personalized pharmacogenetic recommendations, improving drug therapy outcomes.
• Continuous updates ensure g-Nomic remains a relevant resource for clinical decision-making in pharmacogenetics.